GENOWAY |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.97 EUR | +0.25% |
|
+1.02% | -13.70% |
| 2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
| 2023 | GENOWAY : Euroland initiates buy coverage | CF |
Sales per Business
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
Genetically Modified Mouse, Rat and Cell Line Models
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Sales per region
| EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
|---|---|---|---|---|---|
France
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Founder | - | 99-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 15-09-30 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | - | 99-02-28 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
| Director/Board Member | - | - | |
| Chief Executive Officer | - | - | |
Andre Tartar
BRD | Director/Board Member | - | - |
| Director/Board Member | 59 | - | |
Robert Léon
BRD | Director/Board Member | 75 | 03-02-24 |
Laurent Fraisse
BRD | Director/Board Member | - | - |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 9,046,590 | 6,566,389 ( 72.58 %) | 246,705 ( 2.727 %) | 72.58 % |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| -13.70% | 38.23M | |
| +1.12% | 42.59B | |
| +6.77% | 40.65B | |
| +47.92% | 40.57B | |
| -11.96% | 26.77B | |
| +6.01% | 24.81B | |
| -24.92% | 18.17B | |
| -3.63% | 11.7B | |
| +27.16% | 12.05B | |
| +7.30% | 11.1B |
- Stock Market
- Equities
- ALGEN Stock
- Company genOway
